Mouse hematopoietic stem cells and the interaction of c-kit receptor and steel factor. 1991

K Ikuta, and D E Ingolia, and J Friedman, and S Heimfeld, and I L Weissman
Howard Hughes Medical Institute, Stanford, California.

Hematopoietic stem cells (HSCs) are distinguished from other hematopoietic progenitors in bone marrow by their unique ability to undergo multilineage differentiation and self-renewal. Two mouse mutations, dominant spotting (W) and steel (Sl), have pleiotropic effects on hematopoiesis, gametogenesis, and melanoblast development. These two mutations have been shown to be intrinsic (W) and microenvironmental (Sl) defects. Recently, molecular studies revealed that the W and Sl loci encode the c-kit receptor and steel factor (SLF), respectively. The c-kit receptor is expressed on HSCs and hematopoietic progenitors, while SLF is produced by stromal cells. SLF acts on hematopoietic progenitors synergistically with other growth factors. Here we review the effect of these mutations on mouse hematopoiesis, and show that SLF acts on HSCs and other myeloerythroid progenitors, but that it, in our hands, does not play a critical role in HSC generation or self-renewal. Rather, SLF is the most potent co-mitogen (with IL-1, IL-3, IL-6, G-CSF, GM-CSF, or M-CSF) found that acts on these cells, but the effect of such treatments is the rather specific and massive expansion of myeloerythropoiesis, not lymphopoiesis, and perhaps at the expense of HSC self-renewal.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016298 Hematopoietic Cell Growth Factors These growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes. Hematopoietins,Hematopoietic Cell Growth Factor,Hematopoietic Stem Cell Stimulators,Hematopoietic Stem Cell-Activating Factors,Hematopoietic-CGF,Hematopoietic CGF
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D019009 Proto-Oncogene Proteins c-kit A protein-tyrosine kinase receptor that is specific for STEM CELL FACTOR. This interaction is crucial for the development of hematopoietic, gonadal, and pigment stem cells. Genetic mutations that disrupt the expression of PROTO-ONCOGENE PROTEINS C-KIT are associated with PIEBALDISM, while overexpression or constitutive activation of the c-kit protein-tyrosine kinase is associated with tumorigenesis. Antigens, CD117,CD117 Antigens,Receptor, Stem Cell Factor,Stem Cell Factor Receptor,c-kit Protein,c-kit Receptor,kit Proto-Oncogene Protein,p145(c-kit),CD117 Antigen,Proto-Oncogene Protein c-kit,Proto-Oncogene Protein kit,SCF Receptor,p145 c-kit,p145c-kit,Proto Oncogene Protein c kit,Proto Oncogene Protein kit,Proto Oncogene Proteins c kit,Proto-Oncogene Protein, kit,c kit Protein,c kit Receptor,c-kit, Proto-Oncogene Protein,c-kit, Proto-Oncogene Proteins,c-kit, p145,kit Proto Oncogene Protein,p145 c kit,p145c kit
D019089 Stem Cell Factor A hematopoietic growth factor and the ligand of the cell surface c-kit protein (PROTO-ONCOGENE PROTEINS C-KIT). It is expressed during embryogenesis and is a growth factor for a number of cell types including the MAST CELLS and the MELANOCYTES in addition to the HEMATOPOIETIC STEM CELLS. Mast Cell Growth Factor,Steel Factor,c-kit Ligand,kit Ligand,c kit Ligand

Related Publications

K Ikuta, and D E Ingolia, and J Friedman, and S Heimfeld, and I L Weissman
April 2008, Clinical cancer research : an official journal of the American Association for Cancer Research,
K Ikuta, and D E Ingolia, and J Friedman, and S Heimfeld, and I L Weissman
February 1992, Proceedings of the National Academy of Sciences of the United States of America,
K Ikuta, and D E Ingolia, and J Friedman, and S Heimfeld, and I L Weissman
September 1996, Proteins,
K Ikuta, and D E Ingolia, and J Friedman, and S Heimfeld, and I L Weissman
September 1995, Blood,
K Ikuta, and D E Ingolia, and J Friedman, and S Heimfeld, and I L Weissman
January 1999, Blood,
K Ikuta, and D E Ingolia, and J Friedman, and S Heimfeld, and I L Weissman
July 1996, Blood,
K Ikuta, and D E Ingolia, and J Friedman, and S Heimfeld, and I L Weissman
September 1992, Gan to kagaku ryoho. Cancer & chemotherapy,
K Ikuta, and D E Ingolia, and J Friedman, and S Heimfeld, and I L Weissman
September 1994, Experimental hematology,
K Ikuta, and D E Ingolia, and J Friedman, and S Heimfeld, and I L Weissman
September 2003, Experimental hematology,
K Ikuta, and D E Ingolia, and J Friedman, and S Heimfeld, and I L Weissman
April 2004, Experimental hematology,
Copied contents to your clipboard!